NEK11 Regulates CDC25A Degradation and the IR-induced G2/M Checkpoint

Overview

Journal Nat Cell Biol

Specialty Cell Biology

Date 2009 Sep 8

PMID 19734889

Citations 72

Authors

Marina Melixetian

Ditte Kjaersgaard Klein

Claus Storgaard Sorensen

Kristian Helin

Affiliations

Soon will be listed here.

Abstract

DNA damage-induced cell-cycle checkpoints have a critical role in maintaining genomic stability. A key target of the checkpoints is the CDC25A (cell division cycle 25 homologue A) phosphatase, which is essential for the activation of cyclin-dependent kinases and cell-cycle progression. To identify new genes involved in the G2/M checkpoint we performed a large-scale short hairpin RNA (shRNA) library screen. We show that NIMA (never in mitosis gene A)-related kinase 11 (NEK11) is required for DNA damage-induced G2/M arrest. Depletion of NEK11 prevents proteasome-dependent degradation of CDC25A, both in unperturbed and DNA-damaged cells. We show that NEK11 directly phosphorylates CDC25A on residues whose phosphorylation is required for beta-TrCP (beta-transducin repeat-containing protein)-mediated polyubiquitylation and degradation of CDC25A. Furthermore, we demonstrate that CHK1 (checkpoint kinase 1) directly activates NEK11 by phosphorylating it on Ser 273, indicating that CHK1 and NEK11 operate in a single pathway that controls proteolysis of CDC25A. Taken together, these results demonstrate that NEK11 is an important component of the pathway enforcing the G2/M checkpoint, suggesting that genetic mutations in NEK11 may contribute to the development of human cancer.

Citing Articles

Maintaining Genome Integrity: Protein Kinases and Phosphatases Orchestrate the Balancing Act of DNA Double-Strand Breaks Repair in Cancer.

Qin S, Kitty I, Hao Y, Zhao F, Kim W Int J Mol Sci. 2023; 24(12).

PMID: 37373360 PMC: 10299397. DOI: 10.3390/ijms241210212.

NEK6 Regulates Redox Balance and DNA Damage Response in DU-145 Prostate Cancer Cells.

Pavan I, Basei F, Severino M, E Silva I, Issayama L, Mancini M Cells. 2023; 12(2).

PMID: 36672191 PMC: 9856815. DOI: 10.3390/cells12020256.

Proteomic Analysis of Decellularized Extracellular Matrix: Achieving a Competent Biomaterial for Osteogenesis.

Monteiro-Lobato G, Russo P, Winck F, Catalani L Biomed Res Int. 2022; 2022:6884370.

PMID: 36267842 PMC: 9578822. DOI: 10.1155/2022/6884370.

In Mitosis You Are Not: The NIMA Family of Kinases in , Yeast, and Mammals.

Bachus S, Graves D, Fulham L, Akkerman N, Stephanson C, Shieh J Int J Mol Sci. 2022; 23(7).

PMID: 35409400 PMC: 8999480. DOI: 10.3390/ijms23074041.

Gene losses may contribute to subterranean adaptations in naked mole-rat and blind mole-rat.

Zheng Z, Hua R, Xu G, Yang H, Shi P BMC Biol. 2022; 20(1):44.

PMID: 35172813 PMC: 8851862. DOI: 10.1186/s12915-022-01243-0.

References

Yarden R, Pardo-Reoyo S, Sgagias M, Cowan K, Brody L . BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage. Nat Genet. 2002; 30(3):285-9. DOI: 10.1038/ng837. View

Berns K, Hijmans E, Mullenders J, Brummelkamp T, Velds A, Heimerikx M . A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature. 2004; 428(6981):431-7. DOI: 10.1038/nature02371. View

Bartek J, Lukas J . Mammalian G1- and S-phase checkpoints in response to DNA damage. Curr Opin Cell Biol. 2001; 13(6):738-47. DOI: 10.1016/s0955-0674(00)00280-5. View

Bernards R, Brummelkamp T, Beijersbergen R . shRNA libraries and their use in cancer genetics. Nat Methods. 2006; 3(9):701-6. DOI: 10.1038/nmeth921. View

Liu Q, Guntuku S, Cui X, Matsuoka S, Cortez D, Tamai K . Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes Dev. 2000; 14(12):1448-59. PMC: 316686. View

Xu B, Kim St , Kastan M . Involvement of Brca1 in S-phase and G(2)-phase checkpoints after ionizing irradiation. Mol Cell Biol. 2001; 21(10):3445-50. PMC: 100266. DOI: 10.1128/MCB.21.10.3445-3450.2001. View

Noguchi K, Fukazawa H, Murakami Y, Uehara Y . Nucleolar Nek11 is a novel target of Nek2A in G1/S-arrested cells. J Biol Chem. 2004; 279(31):32716-27. DOI: 10.1074/jbc.M404104200. View

Zhou B, Elledge S . The DNA damage response: putting checkpoints in perspective. Nature. 2000; 408(6811):433-9. DOI: 10.1038/35044005. View

Shiloh Y . ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer. 2003; 3(3):155-68. DOI: 10.1038/nrc1011. View

10.

Noguchi K, Fukazawa H, Murakami Y, Uehara Y . Nek11, a new member of the NIMA family of kinases, involved in DNA replication and genotoxic stress responses. J Biol Chem. 2002; 277(42):39655-65. DOI: 10.1074/jbc.M204599200. View

11.

Peng C, Graves P, Thoma R, Wu Z, Shaw A, Piwnica-Worms H . Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science. 1997; 277(5331):1501-5. DOI: 10.1126/science.277.5331.1501. View

12.

Busino L, Chiesa M, Draetta G, Donzelli M . Cdc25A phosphatase: combinatorial phosphorylation, ubiquitylation and proteolysis. Oncogene. 2004; 23(11):2050-6. DOI: 10.1038/sj.onc.1207394. View

13.

Kastan M, Bartek J . Cell-cycle checkpoints and cancer. Nature. 2004; 432(7015):316-23. DOI: 10.1038/nature03097. View

14.

Kohn E, Yoo C, Eastman A . The protein kinase C inhibitor Gö6976 is a potent inhibitor of DNA damage-induced S and G2 cell cycle checkpoints. Cancer Res. 2003; 63(1):31-5. View

15.

Mailand N, Falck J, Lukas C, Syljuasen R, Welcker M, Bartek J . Rapid destruction of human Cdc25A in response to DNA damage. Science. 2000; 288(5470):1425-9. DOI: 10.1126/science.288.5470.1425. View

16.

Molinari M, Mercurio C, Dominguez J, GOUBIN F, Draetta G . Human Cdc25 A inactivation in response to S phase inhibition and its role in preventing premature mitosis. EMBO Rep. 2001; 1(1):71-9. PMC: 1083693. DOI: 10.1093/embo-reports/kvd018. View

17.

Mailand N, Podtelejnikov A, Groth A, Mann M, Bartek J, Lukas J . Regulation of G(2)/M events by Cdc25A through phosphorylation-dependent modulation of its stability. EMBO J. 2002; 21(21):5911-20. PMC: 131064. DOI: 10.1093/emboj/cdf567. View

18.

Tibbetts R, Cortez D, Brumbaugh K, Scully R, Livingston D, Elledge S . Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. Genes Dev. 2000; 14(23):2989-3002. PMC: 317107. DOI: 10.1101/gad.851000. View

19.

ONeill T, Giarratani L, Chen P, Iyer L, Lee C, Bobiak M . Determination of substrate motifs for human Chk1 and hCds1/Chk2 by the oriented peptide library approach. J Biol Chem. 2002; 277(18):16102-15. DOI: 10.1074/jbc.M111705200. View

20.

Jin J, Shirogane T, Xu L, Nalepa G, Qin J, Elledge S . SCFbeta-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase. Genes Dev. 2003; 17(24):3062-74. PMC: 305258. DOI: 10.1101/gad.1157503. View